Form 8-K - Current report:
SEC Accession No. 0001628280-18-011135
Filing Date
2018-08-14
Accepted
2018-08-14 17:23:50
Documents
3
Period of Report
2018-08-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K q220188k-earningsrelease.htm 8-K 35240
2 EXHIBIT 99.1 q22018-ex991earningsrelease.htm EX-99.1 281671
3 cumberlandpharmaimageaa04.jpg GRAPHIC 37721
  Complete submission text file 0001628280-18-011135.txt   370087
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 181018962
SIC: 2834 Pharmaceutical Preparations